Vuong Trieu Insider Trades & Stock Holdings

CHAIRMAN AND CEO · Oncotelic Therapeutics, Inc. · Latest filing Jun 24, 2026

Vuong Trieu, CHAIRMAN AND CEO at Oncotelic Therapeutics, Inc. has 5 Form 4 trades on file since Jun 17, 2026. Open-market activity: 5 purchases ($31.93K) and 0 sales ($0), net +$31.93K. Latest filing: acquired 115K shares of $OTLC on Jun 24, 2026 at $0.05.

Trades on file

5

Open-market bought

$31.93K

Open-market sold

$0

Net open-market

+$31.93K

Latest filing

Jun 24, 2026

All insider trades by Vuong Trieu

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 24, 2026	$OTLC	Buy (Open-market buy)	115K	$0.05	$5.75K			0.0%	0.0%		CHAIRMAN AND CEO		Read
Jun 23, 2026	$OTLC	Buy (Open-market buy)	75K	$0.05	$3.75K			-20.0%	-40.0%		CHAIRMAN AND CEO		Read
Jun 22, 2026	$OTLC	Buy (Open-market buy)	65K	$0.05	$3.25K			-20.0%	-20.0%		CHAIRMAN AND CEO		Read
Jun 17, 2026	$OTLC	Buy (Open-market buy)	239.76K	$0.04	$9.59K			-20.0%	-20.0%		CHAIRMAN AND CEO		—
Jun 17, 2026	$OTLC	Buy (Open-market buy)	239.76K	$0.04	$9.59K			-20.0%	-20.0%		CHAIRMAN AND CEO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Vuong Trieu traded

• $OTLC

Frequently asked questions

Has Vuong Trieu been buying or selling stock?

Vuong Trieu has 5 open-market purchases and 0 open-market sales on file, net +$31.93K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Vuong Trieu's latest insider trade?

acquired 115K shares of $OTLC on Jun 24, 2026 at $0.05.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.